-
1
-
-
1542611654
-
Incidence and risk factors of atrial fibrillation in a surgical intensive care unit
-
Seguin P, Signouret T, Laviolle B, Branger B, Mallédant Y. Incidence and risk factors of atrial fibrillation in a surgical intensive care unit. Crit Care Med 2004; 32: 722-6.
-
(2004)
Crit Care Med
, vol.32
, pp. 722-726
-
-
Seguin, P.1
Signouret, T.2
Laviolle, B.3
Branger, B.4
Mallédant, Y.5
-
2
-
-
0035020164
-
Risk factors associated with new onset tachyarrhythmias after cardiac surgery - a retrospective analysis
-
Mayr A, Knotzer H, Pajk W, et al. Risk factors associated with new onset tachyarrhythmias after cardiac surgery - a retrospective analysis. Acta Anaesthesiol Scand 2001; 45: 543-9.
-
(2001)
Acta Anaesthesiol Scand
, vol.45
, pp. 543-549
-
-
Mayr, A.1
Knotzer, H.2
Pajk, W.3
-
3
-
-
33344463082
-
Atrial fibrillation in trauma patients requiring intensive care
-
Seguin P, Laviolle B, Maurice A, Leclercq C, Mallédant Y. Atrial fibrillation in trauma patients requiring intensive care. Intensive Care Med 2006; 32: 398-404.
-
(2006)
Intensive Care Med
, vol.32
, pp. 398-404
-
-
Seguin, P.1
Laviolle, B.2
Maurice, A.3
Leclercq, C.4
Mallédant, Y.5
-
4
-
-
0036892344
-
Clinical review: Myocardial depression in sepsis and septic shock
-
Court O, Kumar A, Parrillo JE, Kumar A. Clinical review: Myocardial depression in sepsis and septic shock. Crit Care 2002; 6: 500-8.
-
(2002)
Crit Care
, vol.6
, pp. 500-508
-
-
Court, O.1
Kumar, A.2
Parrillo, J.E.3
Kumar, A.4
-
5
-
-
0035846667
-
C-reactive protein elevation in patients with atrial arrhythmias: Inflammatory mechanisms and persistence of atrial fibrillation
-
Chung MK, Martin DO, Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001; 104: 2886-91.
-
(2001)
Circulation
, vol.104
, pp. 2886-2891
-
-
Chung, M.K.1
Martin, D.O.2
Sprecher, D.3
-
6
-
-
11144222675
-
Inhibition of inducible nitric oxide synthase reduces lipopolysaccharide-induced renal injury in the rat
-
Kadkhodaee M, Qasemi A. Inhibition of inducible nitric oxide synthase reduces lipopolysaccharide-induced renal injury in the rat. Clini Exp Pharmacol Physiol 2004; 31: 842-6.
-
(2004)
Clini Exp Pharmacol Physiol
, vol.31
, pp. 842-846
-
-
Kadkhodaee, M.1
Qasemi, A.2
-
7
-
-
17844375087
-
Lipopolysaccharide-induced tyrosine nitration and inactivation of hepatic glutamihe synthetase in the rat
-
Görg B, Wettstein M, Metzger S, Schliess F, Häussinger D. Lipopolysaccharide-induced tyrosine nitration and inactivation of hepatic glutamihe synthetase in the rat. Hepatology 2005; 41: 1065-73.
-
(2005)
Hepatology
, vol.41
, pp. 1065-1073
-
-
Görg, B.1
Wettstein, M.2
Metzger, S.3
Schliess, F.4
Häussinger, D.5
-
8
-
-
8844250922
-
Lipopolysaccharide suppresses albumin expression by activating NF-kappa B in rat hepatocytes
-
Wang X, Li W, Lu J, Li N, Li J. Lipopolysaccharide suppresses albumin expression by activating NF-kappa B in rat hepatocytes. J Surg Res 2004; 122: 274-9.
-
(2004)
J Surg Res
, vol.122
, pp. 274-279
-
-
Wang, X.1
Li, W.2
Lu, J.3
Li, N.4
Li, J.5
-
9
-
-
0034463964
-
Administration of bacterial lipopolysaccharide to rats induces heme oxygenase-1 and formation of antioxidant bilirubin in the intestinal mucosa
-
Otani K, Shimizu S, Chijiiwa K, et al. Administration of bacterial lipopolysaccharide to rats induces heme oxygenase-1 and formation of antioxidant bilirubin in the intestinal mucosa. Dig Dis Sci 2000; 45: 2313-9.
-
(2000)
Dig Dis Sci
, vol.45
, pp. 2313-2319
-
-
Otani, K.1
Shimizu, S.2
Chijiiwa, K.3
-
10
-
-
8844248001
-
Oral arginine reduces gut mucosal injury caused by lipopolysaccharide endotoxemia in rat
-
Sukhotnik I, Mogilner J, Krausz MM, et al. Oral arginine reduces gut mucosal injury caused by lipopolysaccharide endotoxemia in rat. J Surg Res 2004; 122: 256-62.
-
(2004)
J Surg Res
, vol.122
, pp. 256-262
-
-
Sukhotnik, I.1
Mogilner, J.2
Krausz, M.M.3
-
11
-
-
18844457358
-
Minocycline attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain
-
Fan LW, Pang Y, Lin S, Rhodes PG, Cai Z. Minocycline attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain. Neuroscience 2005; 133: 159-68.
-
(2005)
Neuroscience
, vol.133
, pp. 159-168
-
-
Fan, L.W.1
Pang, Y.2
Lin, S.3
Rhodes, P.G.4
Cai, Z.5
-
12
-
-
36549008718
-
Reduced L-type calcium current in ventricular myocytes from endotoxemic guinea pigs
-
Zhong J, Hwang TC, Adams HR, Rubin LJ. Reduced L-type calcium current in ventricular myocytes from endotoxemic guinea pigs. Am J Physiol 1997; 273: H2312-24.
-
(1997)
Am J Physiol
, vol.273
-
-
Zhong, J.1
Hwang, T.C.2
Adams, H.R.3
Rubin, L.J.4
-
13
-
-
0032884049
-
Sequential changes in autonomic regulation of cardiac myocytes after in vivo endotoxin injection in rat
-
Abi-Gerges N, Tavernier B, Mebazaa A, et al. Sequential changes in autonomic regulation of cardiac myocytes after in vivo endotoxin injection in rat. Am J Respir Crit Care Med 1999; 160: 1196-204.
-
(1999)
Am J Respir Crit Care Med
, vol.160
, pp. 1196-1204
-
-
Abi-Gerges, N.1
Tavernier, B.2
Mebazaa, A.3
-
14
-
-
0030002538
-
Endotoxin-induced cardiac depression is associated with decreased cardiac dihydropyridine receptors in rabbits
-
Lew WY, Yasuda S, Yuan T, Hammond KH. Endotoxin-induced cardiac depression is associated with decreased cardiac dihydropyridine receptors in rabbits. J Mol Cell Cardiol 1996; 28: 1367-71.
-
(1996)
J Mol Cell Cardiol
, vol.28
, pp. 1367-1371
-
-
Lew, W.Y.1
Yasuda, S.2
Yuan, T.3
Hammond, K.H.4
-
15
-
-
0025174741
-
Myocardial beta adrenergic receptor coupling to adenylate cyclase during developing septic shock
-
Jones SB, Romano FD. Myocardial beta adrenergic receptor coupling to adenylate cyclase during developing septic shock. Circ Shock 1990; 30: 51-61.
-
(1990)
Circ Shock
, vol.30
, pp. 51-61
-
-
Jones, S.B.1
Romano, F.D.2
-
16
-
-
20244366952
-
Thyroid hormone regulates mRNA expression and currents of ion channels in rat atrium
-
Watanabe H, Ma M, Washizuka T, et al. Thyroid hormone regulates mRNA expression and currents of ion channels in rat atrium. Biochem Biophys Res Commun 2003; 308: 439-44.
-
(2003)
Biochem Biophys Res Commun
, vol.308
, pp. 439-444
-
-
Watanabe, H.1
Ma, M.2
Washizuka, T.3
-
17
-
-
0037446681
-
Orcadian variation of cardiac K+ channel gene expression
-
Yamashita T, Sekiguchi A, Iwasaki YK, et al. Orcadian variation of cardiac K+ channel gene expression. Circulation 2003; 107: 1917-22.
-
(2003)
Circulation
, vol.107
, pp. 1917-1922
-
-
Yamashita, T.1
Sekiguchi, A.2
Iwasaki, Y.K.3
-
18
-
-
0345688078
-
Thrombomodulin and tissue factor pathway inhibitor in endocardium of rapidly paced rat atria
-
Yamashita T, Sekiguchi A, Iwasaki YK, et al. Thrombomodulin and tissue factor pathway inhibitor in endocardium of rapidly paced rat atria. Circulation 2003; 108: 2450-2.
-
(2003)
Circulation
, vol.108
, pp. 2450-2452
-
-
Yamashita, T.1
Sekiguchi, A.2
Iwasaki, Y.K.3
-
19
-
-
0842327240
-
Cecropin B enhances beta lactam activities in experimental rat models of gram-negative septic shock
-
Ghiselli R, Giacometti A, Cirioni O, et al. Cecropin B enhances beta lactam activities in experimental rat models of gram-negative septic shock. Ann Surg 2004; 239: 251-6.
-
(2004)
Ann Surg
, vol.239
, pp. 251-256
-
-
Ghiselli, R.1
Giacometti, A.2
Cirioni, O.3
-
20
-
-
0642312183
-
Toll-like receptors in cardiovascular diseases
-
de Kleijn D, Pasterkamp G. Toll-like receptors in cardiovascular diseases. Cardiovasc Res 2003; 60: 58-67.
-
(2003)
Cardiovasc Res
, vol.60
, pp. 58-67
-
-
de Kleijn, D.1
Pasterkamp, G.2
-
21
-
-
0032701642
-
Toll 4 (TLR4) expression in cardiac myocytes in normal and failing myocardium
-
Frantz S, Kobzik L, Kim YD, et al. Toll 4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J Clin Invest 1999; 104: 271-80.
-
(1999)
J Clin Invest
, vol.104
, pp. 271-280
-
-
Frantz, S.1
Kobzik, L.2
Kim, Y.D.3
-
22
-
-
4944254828
-
Immune cell Toll-like receptor 4 is required for cardiac myocyte impairment during endotoxemia
-
Tavener SA, Long EM, Robbins SM, McRae KM, Van Remmen H, Kubes P. Immune cell Toll-like receptor 4 is required for cardiac myocyte impairment during endotoxemia. Circ Res 2004; 95: 700-7.
-
(2004)
Circ Res
, vol.95
, pp. 700-707
-
-
Tavener, S.A.1
Long, E.M.2
Robbins, S.M.3
McRae, K.M.4
Van Remmen, H.5
Kubes, P.6
-
23
-
-
33644869495
-
Cellular and molecular mechanisms underlying LPS-associated myocyte impairment
-
Tavener SA, Kubes P. Cellular and molecular mechanisms underlying LPS-associated myocyte impairment. Am J Physiol Heart Circ Physiol 2006; 290: H800-6.
-
(2006)
Am J Physiol Heart Circ Physiol
, vol.290
-
-
Tavener, S.A.1
Kubes, P.2
-
24
-
-
33846188153
-
Transforming growth factor-beta1 decreases cardiac muscle L-type Ca2+ current and charge movement by acting on the Cav1.2 mRNA
-
Avila G, Medina IM, Jiménez E, Elizondo G, Aguilar CI. Transforming growth factor-beta1 decreases cardiac muscle L-type Ca2+ current and charge movement by acting on the Cav1.2 mRNA. Am J Physiol Heart Circ Physiol 2007; 292: H622-31.
-
(2007)
Am J Physiol Heart Circ Physiol
, vol.292
-
-
Avila, G.1
Medina, I.M.2
Jiménez, E.3
Elizondo, G.4
Aguilar, C.I.5
-
25
-
-
23044463854
-
Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation
-
Gaborit N, Steenman M, Lamirault G, et al. Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation. Circulation 2005; 112: 471-81.
-
(2005)
Circulation
, vol.112
, pp. 471-481
-
-
Gaborit, N.1
Steenman, M.2
Lamirault, G.3
|